Examining the Circadian Timing Effects of the Hypotensive Response to Exercise
NCT ID: NCT07049783
Last Updated: 2025-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2025-07-22
2026-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
• When the same participant exercises at different times of day (morning, afternoon, or evening), how does this affect the participant's blood pressure over the next 24 hours?
Participants will:
* Undergo an in-lab assessment of individual biological rhythm that will indicate the clock-time for an individual's biological night
* Complete 3 supervised treadmill exercise sessions
* 1 in the biological morning (biological night + 10 hours)
* 1 in the biological afternoon (biological night + 15 hours)
* 1 in the biological evening (biological night + 20 hours)
* Complete a 24-hour blood pressure assessment before and after each exercise session
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise and Vascular Function in Postmenopausal Females With Hypertension
NCT05597033
AM vs PM Exercise Training
NCT06042439
Physical Exercise in Hypertension, Randomised Clinical Trial
NCT00218972
High-Intensity Interval Training on Pre-Hypertensive Subjects
NCT03000140
Effects of Physical Exercise Timing On Strength and Cardiometabolic Health
NCT06063135
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Morning
Exercise 10 hours after dim-light melatonin onset
Exercise
A single standardized, in-lab, 30-minute monitored treadmill exercise session
Afternoon
Exercise 15 hours after dim-light melatonin onset
Exercise
A single standardized, in-lab, 30-minute monitored treadmill exercise session
Evening
Exercise 20 hours after dim-light melatonin onset
Exercise
A single standardized, in-lab, 30-minute monitored treadmill exercise session
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise
A single standardized, in-lab, 30-minute monitored treadmill exercise session
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Resting blood pressure greater than or equal to 120/80 mmHg or less than 140/90 mmHg
Exclusion Criteria
* Diagnosis or history of sleep disorder (i.e., obstructive sleep apnea, insomnia, restless leg syndrome)
* Alcohol or drug dependence
* Elevated risk for sleep disorders
* Elevated risk for clinical depression
* Normotensive (blood pressure less than 120/80 mmHg) or stage 2+ hypertension (blood pressure greater than or equal to 140/90 mmHg)
* Body mass index less than 18.5 or greater than 35 kg/m2
* Self-reported use of sleep medications/supplements (e.g., melatonin)
* Self-reported use of medications influencing vascular physiology (e.g., antihypertensive medications, weight loss medications)
* Highly physically active (greater than or equal to 300 minutes moderate-to-vigorous physical activity per week)
* Currently pregnant or breastfeeding
* Current tobacco use (greater than or equal to 1 cigarette in the past month)
* Nighttime or rotating shift work within the last 3 months
* Contraindications to aerobic exercise
18 Years
39 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Freda Patterson
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Freda Patterson
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Delaware
Newark, Delaware, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2324519-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.